Huntington National Bank’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.8K | Buy |
199
+14
| +8% | +$1.46K | ﹤0.01% | 1555 |
|
|
2025
Q1 | $21.6K | Sell |
185
-29
| -14% | -$3.38K | ﹤0.01% | 1490 |
|
|
2024
Q4 | $18.1K | Sell |
214
-1
| -0.5% | -$85 | ﹤0.01% | 1572 |
|
|
2024
Q3 | $19.3K | Buy |
215
+2
| +0.9% | +$180 | ﹤0.01% | 1520 |
|
|
2024
Q2 | $17.1K | Sell |
213
-123
| -37% | -$9.9K | ﹤0.01% | 1507 |
|
|
2024
Q1 | $26.8K | Sell |
336
-14
| -4% | -$1.12K | ﹤0.01% | 1374 |
|
|
2023
Q4 | $27.9K | Buy |
350
+2
| +0.6% | +$159 | ﹤0.01% | 1317 |
|
|
2023
Q3 | $24.3K | Sell |
348
-13
| -4% | -$909 | ﹤0.01% | 1295 |
|
|
2023
Q2 | $25.9K | Buy |
361
+45
| +14% | +$3.23K | ﹤0.01% | 1278 |
|
|
2023
Q1 | $19.5K | Sell |
316
-51
| -14% | -$3.15K | ﹤0.01% | 1322 |
|
|
2022
Q4 | $28.3K | Buy |
367
+36
| +11% | +$2.78K | ﹤0.01% | 1174 |
|
|
2022
Q3 | $14K | Hold |
331
| – | – | ﹤0.01% | 1419 |
|
|
2022
Q2 | $13K | Hold |
331
| – | – | ﹤0.01% | 1476 |
|
|
2022
Q1 | $14K | Sell |
331
-1
| -0.3% | -$42 | ﹤0.01% | 1475 |
|
|
2021
Q4 | $13K | Sell |
332
-75
| -18% | -$2.94K | ﹤0.01% | 1499 |
|
|
2021
Q3 | $13K | Buy |
407
+70
| +21% | +$2.24K | ﹤0.01% | 1366 |
|
|
2021
Q2 | $23K | Buy |
337
+63
| +23% | +$4.3K | ﹤0.01% | 1177 |
|
|
2021
Q1 | $16K | Buy |
+274
| New | +$16K | ﹤0.01% | 1201 |
|
|
2020
Q1 | – | Sell |
-500
| Closed | -$52K | – | 1540 |
|
|
2019
Q4 | $52K | Buy |
+500
| New | +$52K | ﹤0.01% | 924 |
|